Antitumor activity against human HL-60 cells in xenografted model assessed as reduction in CD33+/CD45+ in bone marrow at 2.5 mg/kg, BID administered f...

Basic Information

ID: ALA4714196

Type: Functional

Description: Antitumor activity against human HL-60 cells in xenografted model assessed as reduction in CD33+/CD45+ in bone marrow at 2.5 mg/kg, BID administered for 10 consecutive days relative to control

Format: BAO_0000218

Organism: Homo sapiens

Cell type: HL-60

Target:  HL-60(ALA383)

Document:  ALA4706692

Antitumor activity against human HL-60 cells in xenografted model assessed as reduction in CD33+/CD45+ in bone marrow at 2.5 mg/kg, BID administered for 10 consecutive days relative to control: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
461.852.512.51